Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenma Yizhi Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiyuan Hospital of the China Academy of Traditional Chinese Medicine. It is primarily investigated for the treatment of vascular dementia (VD), specifically targeting patients diagnosed with the TCM syndrome of deficiency, blood stasis, and liver-yang deficiency. The decoction is intended to improve cognitive function and address neurological defects. As a complex herbal mixture, its pharmacological profile likely involves synergistic effects such as enhancing cerebral blood flow, reducing oxidative stress, and providing neuroprotection, although specific molecular targets have not been definitively characterized in clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenma yizhi decoction.